APA (7th ed.) Citation

S, M., T, B., V, G., F, K., E, S., J, H., . . . E, U. (2020). High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia. Frontiers in immunology, 10, 3123. https://doi.org/10.3389/fimmu.2019.03123

Chicago Style (17th ed.) Citation

S, Müller, et al. "High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia." Frontiers in Immunology 10 (2020): 3123. https://doi.org/10.3389/fimmu.2019.03123.

MLA (9th ed.) Citation

S, Müller, et al. "High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia." Frontiers in Immunology, vol. 10, 2020, p. 3123, https://doi.org/10.3389/fimmu.2019.03123.